Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
Amneal (Nasdaq: AMRX) announced that Co-Chief Executive and President Chirag Patel will present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 in Miami, FL.
Rhea-AI Summary
Amneal (Nasdaq: AMRX) announced that Co-Chief Executive and President Chirag Patel will present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 in Miami, FL. The company presentation is scheduled for Tuesday, June 9, 2026, at 8:40 AM EDT.
Positive
- None.
Negative
- None.
Details
News Market Reaction – AMRX
On Jun 1, the day this news came out, AMRX closed 2.05% below the previous close.
Data tracked by StockTitan Argus for the Jun 1 session.
Key Figures
- Conference dates
- June 8–10, 2026
- Goldman Sachs 47th Annual Global Healthcare Conference
- Company presentation date
- June 9, 2026
- Amneal presentation at Goldman Sachs conference
- Presentation time
- 8:40 AM EDT
- Scheduled time for Amneal conference presentation
Historical Context
-
Reported Q1 2026 results and affirmed raised full-year guidance.
-
Agreed to acquire Kashiv BioSciences to build biosimilars platform.
-
Detailed Kashiv acquisition terms plus strong preliminary Q1 results.
-
Positive interim Phase 4 ELEVATE-PD data for CREXONT in Parkinson’s.
-
Launched first two U.S. respiratory MDI generics with sizeable markets.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BRIDGEWATER, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), today announced that Chirag Patel, Co-Chief Executive and President, will participate and present at Goldman Sachs 47th Annual Global Healthcare Conference 2026 being held on June 8-10 at the Loews Miami Beach Hotel in Miami, FL.
A company presentation will take place on Tuesday June 9, 2026, at 8:40AM EDT. A live webcast of the presentation will be available here.
About Amneal
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, New Jersey, is a diversified, global biopharmaceutical leader focused on expanding access to affordable and innovative medicines. Amneal was founded in 2002 by brothers and co-CEOs Chirag and Chintu Patel, and built on the belief that innovation only matters if it’s accessible. Today, Amneal has a diverse and growing portfolio of approximately 300 complex generic, specialty and biosimilar medicines, delivering more than 160 million prescriptions annually, primarily in the United States. Our Affordable Medicines segment spans retail generics, injectables, and biosimilars. Our Specialty segment provides branded treatments in neurology, including Parkinson’s disease and migraine, and endocrinology. Our AvKARE segment distributes pharmaceuticals and medical products to U.S. federal, retail, and institutional customers. For additional information, please visit amneal.com and follow us on LinkedIn.
Investor Contact
Anthony DiMeo
VP, Investor Relations
anthony.dimeo@amneal.com
Media Contact
Brandon Skop
Sr. Director, Corporate Communications
brandon.skop@amneal.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.